MPS Pharmaa Ltd | 7.99 Cr. | 4.18 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 3,142 Cr. | 288 | 390/210 | 59.6 | 20.5 | 0.23 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 56.7 Cr. | 76.4 | 94.9/27.0 | 19.2 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 39.7 Cr. | 27.1 | 28.0/8.74 | 40.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 81.0 Cr. | 108 | 155/87.0 | 12.2 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 317 Cr. | 13.9 | 29.0/13.1 | 18.3 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 341 Cr. | 725 | 1,054/635 | 18.1 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 102 Cr. | 23.2 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 1,152 Cr. | 391 | 440/145 | 140 | 98.6 | 0.32 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.71 Cr. | 32.0 | 43.8/23.6 | 134 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 17.2 Cr. | 6.90 | 14.7/6.72 | 38.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 245 Cr. | 253 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 6,224 Cr. | 1,431 | 1,584/970 | 87.1 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 165 Cr. | 1.77 | 2.97/1.03 | 34.9 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 36.3 Cr. | 15.1 | 16.6/6.40 | 43.8 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 14.0 Cr. | 13.9 | 24.6/13.5 | 16.9 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 278 Cr. | 780 | 999/345 | 12.0 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 35.4 Cr. | 35.4 | 48.5/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 25.0 Cr. | 54.8 | 84.4/36.0 | 51.1 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.20 Cr. | 3.28 | 26.5/2.97 | 32.8 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 10.9 Cr. | 72.7 | 154/52.2 | 27.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 6.96 Cr. | 12.7 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 47.5 Cr. | 63.0 | 148/60.0 | 30.1 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.77 Cr. | 19.2 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 14,261 Cr. | 822 | 845/329 | 60.8 | 53.3 | 0.12 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 108 Cr. | 24.9 | 40.0/22.2 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 16.8 Cr. | 33.2 | 46.0/26.0 | 49.4 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 190 Cr. | 329 | 418/250 | 19.5 | 110 | 1.37 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 28.2 Cr. | 47.9 | 62.6/7.88 | 80.6 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 69,844 Cr. | 1,192 | 1,593/958 | 19.6 | 527 | 0.38 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 145 Cr. | 233 | 307/137 | 23.5 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 1,022 Cr. | 204 | 265/165 | 20.3 | 60.5 | 1.23 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 52.5 Cr. | 40.2 | 70.0/37.2 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 10,194 Cr. | 2,493 | 2,644/1,004 | 83.8 | 294 | 0.12 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 6.61 Cr. | 1.00 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 408 Cr. | 53.2 | 77.7/39.2 | 30.6 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 102 Cr. | 4.35 | 6.25/2.87 | 155 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 63,279 Cr. | 29,800 | 30,683/25,200 | 47.4 | 1,657 | 1.38 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,715 Cr. | 741 | 771/381 | 26.9 | 205 | 0.40 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 139 Cr. | 49.7 | 75.8/37.0 | 20.1 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,693 Cr. | 982 | 1,078/440 | | 58.0 | 0.10 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 26,003 Cr. | 1,599 | 1,680/420 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 792 Cr. | 242 | 325/122 | 28.7 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 482 Cr. | 361 | 428/270 | 17.3 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 5,155 Cr. | 730 | 950/433 | 60.9 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,809 Cr. | 1,280 | 1,923/1,241 | 26.4 | 735 | 0.78 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,10,277 Cr. | 3,259 | 3,591/2,488 | 59.2 | 222 | 0.86 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 2,140 Cr. | 232 | 317/181 | 40.4 | 44.8 | 0.22 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,733 Cr. | 18.4 | 27.9/11.0 | 54.6 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 29,395 Cr. | 1,158 | 1,360/597 | 121 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,874 Cr. | 132 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,19,715 Cr. | 1,750 | 1,960/1,377 | 35.6 | 288 | 0.77 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,266 Cr. | 534 | 886/322 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,846 Cr. | 217 | 398/134 | 31.5 | 70.6 | 0.18 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 387 Cr. | 1,260 | 1,750/538 | 19.0 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 7,156 Cr. | 733 | 960/358 | 125 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,959 Cr. | 158 | 241/91.8 | 186 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 12,605 Cr. | 5,472 | 7,600/4,606 | 29.9 | 298 | 3.05 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 4,136 Cr. | 2,496 | 2,977/1,360 | 43.3 | 229 | 0.64 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 9,037 Cr. | 5,434 | 5,850/4,637 | 39.9 | 324 | 1.10 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 261 Cr. | 74.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,931 Cr. | 4,358 | 6,453/3,950 | 32.4 | 820 | 0.80 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 234 Cr. | 190 | 348/180 | 12.8 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,544 Cr. | 414 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 7,097 Cr. | 1,400 | 1,998/913 | 59.6 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 18,295 Cr. | 14,247 | 18,100/5,532 | 69.3 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 817 Cr. | 37.9 | 56.5/26.2 | 48.1 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 23,643 Cr. | 1,319 | 1,639/828 | 12.2 | 399 | 0.72 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,354 Cr. | 61.2 | 101/38.6 | 26.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 12,371 Cr. | 273 | 359/126 | 35.8 | 50.3 | 0.22 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 178 Cr. | 113 | 145/85.2 | 18.9 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 497 Cr. | 140 | 177/97.9 | 121 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 1,00,442 Cr. | 2,201 | 2,403/1,493 | 38.2 | 343 | 0.36 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,504 Cr. | 749 | 980/498 | 15.6 | 319 | 0.24 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 34,609 Cr. | 641 | 646/372 | 139 | 79.2 | 0.12 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 839 Cr. | 808 | 1,070/405 | 23.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 222 Cr. | 103 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 889 Cr. | 183 | 370/174 | 16.8 | 103 | 1.64 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 524 Cr. | 326 | 462/298 | 37.3 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 15,919 Cr. | 1,000 | 1,310/538 | 47.8 | 373 | 0.50 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,978 Cr. | 1,671 | 2,030/1,474 | 40.6 | 207 | 0.73 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,773 Cr. | 267 | 328/108 | 48.6 | 29.7 | 0.75 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 38,216 Cr. | 1,507 | 1,758/1,052 | 61.3 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,257 Cr. | 384 | 538/331 | 22.5 | 283 | 1.30 % | 12.3 % | 8.68 % | 10.0 |
Ind-Swift Ltd | 85.3 Cr. | 15.9 | 34.7/14.3 | 1.55 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 611 Cr. | 103 | 186/86.2 | 5.98 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,591 Cr. | 280 | 388/242 | | 118 | 0.54 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,644 Cr. | 377 | 465/260 | 62.3 | 97.6 | 0.32 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,596 Cr. | 1,877 | 3,379/1,293 | 51.7 | 355 | 0.32 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 4,193 Cr. | 419 | 504/278 | 49.4 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 14,130 Cr. | 583 | 725/382 | 29.5 | 141 | 0.26 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 43,509 Cr. | 1,540 | 1,831/767 | | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 37,315 Cr. | 2,208 | 3,088/1,825 | 46.5 | 98.7 | 1.45 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 24,956 Cr. | 1,517 | 2,221/1,414 | 22.3 | 557 | 1.32 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 7,692 Cr. | 472 | 659/405 | 24.3 | 141 | 1.06 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 20,045 Cr. | 1,479 | 1,594/809 | 60.9 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,03,548 Cr. | 1,240 | 1,421/1,120 | 19.3 | 369 | 0.64 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,838 Cr. | 245 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,18,889 Cr. | 1,472 | 1,702/1,317 | 23.9 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 16,904 Cr. | 2,217 | 2,641/1,221 | 32.8 | 334 | 0.23 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 412 Cr. | 156 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,572 Cr. | 149 | 186/92.2 | 18.6 | 95.8 | 0.33 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 87.1 Cr. | 53.6 | 92.0/49.0 | 164 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 46,451 Cr. | 387 | 405/244 | 56.4 | 175 | 0.13 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,804 Cr. | 1,877 | 2,326/1,060 | 44.0 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 177 Cr. | 111 | 158/89.0 | 23.2 | 43.2 | 1.08 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 191 Cr. | 80.6 | 113/73.2 | 40.8 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,043 Cr. | 7,612 | 8,140/4,050 | 148 | 272 | 0.32 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,908 Cr. | 657 | 863/574 | 40.1 | 103 | 0.70 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 242 Cr. | 115 | 145/69.9 | 11.6 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 61,582 Cr. | 5,151 | 6,440/4,407 | 28.5 | 961 | 0.78 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,443 Cr. | 887 | 1,304/823 | 29.4 | 249 | 1.24 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 665 Cr. | 1,168 | 1,754/1,010 | 9.71 | 724 | 0.98 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 33,622 Cr. | 2,692 | 3,486/1,998 | 37.4 | 294 | 1.34 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,708 Cr. | 331 | 571/312 | 25.3 | 120 | 1.54 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,830 Cr. | 416 | 635/387 | 29.0 | 126 | 0.24 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 18,183.90 Cr | 1,157.58 | | 47.27 | 184.84 | 0.33% | 16.18% | 16.43% | 6.27 |